4 Largecap Stocks With Rs 10,000-20,000 Crore Profit to Watch for Future Multibagger Potential: L&T, Sun Pharma, Bajaj Auto and Hindustan Zinc
- October 21, 2026
- Posted by: Manan Bisht
- Category: Best Stocks
L&T Rs 3,661.90. Sun Pharma Rs 1,743. Bajaj Auto Rs 10,287. Hindustan Zinc Rs 538.40. Market caps from Rs 2.24 lakh crore to Rs 5.00 lakh crore. Data as of 20 Oct 2026.
Quick Answer
L&T, Sun Pharma, Bajaj Auto and Hindustan Zinc are the 4 picks in this stocks with Rs 10,000-20,000 crore profit watchlist, with market caps between Rs 2.24 lakh crore and Rs 5.00 lakh crore. L&T stands out for the largest market cap at Rs 5,00,275 crore, while Sun Pharma offers the fastest profit growth, 35.75% a year since FY22. PE ratios run from 13.12 to 34.86, so compare each one with its industry PE before investing. All figures are as of 20 October 2026.
Stocks with Rs 10,000-20,000 crore profit to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. L&T, Sun Pharma, Bajaj Auto and Hindustan Zinc meet that test, with market caps from Rs 2.24 lakh crore to Rs 5.00 lakh crore and L&T offering the largest market cap at Rs 5,00,275 crore. Each of these companies reported FY26 net profit between Rs 10,000 crore and Rs 20,000 crore, and net profit rose in FY26 and in the latest quarter.
This list covers companies with FY26 net profit between Rs 10,000 crore and Rs 20,000 crore, rising profit in FY26 and the latest quarter, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap above Rs 1 lakh crore. Investors screening stocks with Rs 10,000-20,000 crore profit usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 20 October 2026 and are drawn from NSE and BSE data and company filings.
Click Here – Get Free Investment Predictions
What Are Stocks With Rs 10,000-20,000 Crore Profit and Why Do They Attract Multibagger Interest?
Stocks with Rs 10,000-20,000 crore profit are shares of companies with a proven record of earning large profits. The four here cover engineering, pharmaceuticals, motorcycles and zinc.
Profit at this scale shows a business that has proven itself over many years. Investors who follow stocks with Rs 10,000-20,000 crore profit look at whether growth can continue from a large base. Investors researching stocks with Rs 10,000-20,000 crore profit get a fuller picture by reading growth and valuation together. The table below lines up stocks with Rs 10,000-20,000 crore profit on size, growth and valuation, using complete FY26 and latest quarter numbers. Past performance does not guarantee future returns, so use stocks with Rs 10,000-20,000 crore profit as a starting point for your own research.
Stocks With Rs 10,000-20,000 Crore Profit at a Glance: Price, Market Cap, PE and ROE
Prices are closing prices as of 20 October 2026. Hindustan Zinc combines the lowest PE of the group, 13.12, with the highest return on equity, 61.13%.
| Stock | CMP (Rs) | Market Cap (Rs Cr) | PE | Industry PE | ROE | Debt to Equity | 52-Week Range (Rs) |
|---|---|---|---|---|---|---|---|
| Larsen & Toubro | 3,661.90 | 5,00,275 | 25.49 | 22.89 | 14.72% | 1.15 | 3,288.10 to 4,440.00 |
| Sun Pharmaceutical Industries | 1,743 | 4,22,427 | 34.86 | 36.42 | 13.74% | 0.06 | 1,583.70 to 2,046.90 |
| Bajaj Auto | 10,287 | 2,81,374 | 24.36 | 23.82 | 27.67% | 0.58 | 8,605.00 to 12,470.00 |
| Hindustan Zinc | 538.40 | 2,23,984 | 13.12 | 12.27 | 61.13% | 0.39 | 412.25 to 609.05 |
L&T: Five-Year Gain of 104.68%
Larsen & Toubro is the largest engineering and construction company in India, with additional businesses in IT services and infrastructure projects. It reported FY26 revenue of Rs 2,91,635.04 crore, up 12.23% year on year, and net profit of Rs 19,159.40 crore, up 8.32%. Net profit has compounded at 16.81% a year since FY22, while revenue has grown 16.41% a year. Operating margin was 14.13% in FY26.
In the June 2026 quarter, revenue rose 8.12% to Rs 70,318.47 crore and net profit grew 15.20% to Rs 4,982.85 crore. The share price has gained 104.68% over five years. The stock trades at a PE of 25.49 against an industry PE of 22.89, with a return on equity of 14.72%.
Sun Pharma: 35.75% Profit CAGR Since FY22
Sun Pharmaceutical Industries is one of India’s largest drugmakers and sells generic and specialty medicines in India and overseas. It reported FY26 revenue of Rs 61,673.94 crore, up 12.69% year on year, and net profit of Rs 11,564.52 crore, up 5.32%. Net profit has compounded at 35.75% a year since FY22, while revenue has grown 11.62% a year. Operating margin was 31.47% in FY26. The debt-to-equity ratio is 0.06, which keeps interest costs low.
The stock trades at a PE of 34.86 against an industry PE of 36.42, below the sector average, with a return on equity of 13.74%. In the June 2026 quarter, revenue rose 11.93% to Rs 16,023.50 crore and net profit grew 26.41% to Rs 2,910.80 crore. The share price has gained 110.81% over five years. Domestic institutions raised their holding from 20.23% in September 2025 to 22.27% in September 2026.
Bajaj Auto: Revenue Up 24.05% in FY26
Bajaj Auto makes motorcycles, three-wheelers and electric two-wheelers, and has a large export business. It reported FY26 revenue of Rs 65,087.22 crore, up 24.05% year on year, and net profit of Rs 10,574.50 crore, up 44.37%. Net profit has compounded at 14.44% a year since FY22, while revenue has grown 17.26% a year. Operating margin was 25.06% in FY26.
In the June 2026 quarter, revenue rose 64.02% to Rs 22,376.69 crore and net profit grew 44.26% to Rs 3,188.75 crore. The share price has gained 165.89% over five years and 13.76% over the past year. Domestic institutions raised their holding from 12.09% in June 2025 to 13.54% in June 2026. The stock trades at a PE of 24.36 against an industry PE of 23.82, with a return on equity of 27.67%.
Hindustan Zinc: Return on Equity of 61.13%
Hindustan Zinc is among the world’s largest integrated zinc producers and also produces lead and silver. It reported FY26 revenue of Rs 41,934 crore, up 19.59% year on year, and net profit of Rs 13,832 crore, up 33.60%. Net profit has compounded at 9.48% a year since FY22, while revenue has grown 8.15% a year. Operating margin was 56.75% in FY26. The debt-to-equity ratio is 0.39.
The stock trades at a PE of 13.12 against an industry PE of 12.27, with a return on equity of 61.13%. The dividend yield is 1.89%. In the June 2026 quarter, revenue rose 74.70% to Rs 14,063 crore and net profit grew 144.81% to Rs 5,469 crore. Foreign investors raised their holding from 1.31% in September 2025 to 2.36% in September 2026.
Stocks With Rs 10,000-20,000 Crore Profit: Financial Comparison on Growth and Margins
The table compares scale and growth across these stocks with Rs 10,000-20,000 crore profit. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.
| Stock | Revenue (Rs Cr) | Net Profit (Rs Cr) | Revenue Growth (YoY) | 4-Year Revenue CAGR | 4-Year Net Profit CAGR | Operating Margin (Latest Quarter) |
|---|---|---|---|---|---|---|
| L&T | 2,91,635.04 | 19,159.40 | 12.23% | 16.41% | 16.81% | 15.49% |
| Sun Pharma | 61,673.94 | 11,564.52 | 12.69% | 11.62% | 35.75% | 32.52% |
| Bajaj Auto | 65,087.22 | 10,574.50 | 24.05% | 17.26% | 14.44% | 24.99% |
| Hindustan Zinc | 41,934 | 13,832 | 19.59% | 8.15% | 9.48% | 64.19% |
Check the Univest Screener for live data on these stocks with Rs 10,000-20,000 crore profit
Institutional Holding in L&T, Sun Pharma, Bajaj Auto and Hindustan Zinc
Institutional holding shows who is backing these stocks with Rs 10,000-20,000 crore profit alongside the promoter. The table uses the latest reported quarter for each. L&T has the deepest institutional backing, with FII and DII together holding 62.15% as of June 2026. Domestic institutions increased their holding over the past year in Sun Pharma (from 20.23% to 22.27%) and Bajaj Auto (from 12.09% to 13.54%).
| Stock | Promoter | FII | DII | Public | Quarter |
|---|---|---|---|---|---|
| L&T | Nil | 19.13% | 43.02% | 37.85% | June 2026 |
| Sun Pharma | 52.68% | 14.36% | 22.27% | 10.70% | September 2026 |
| Bajaj Auto | 55.01% | 9.01% | 13.54% | 22.44% | June 2026 |
| Hindustan Zinc | 60.71% | 2.36% | 4.85% | 32.07% | September 2026 |
Risks to Weigh in Stocks With Rs 10,000-20,000 Crore Profit
Being careful with stocks with Rs 10,000-20,000 crore profit means looking at what can slow the story as well as what can speed it up. Four points matter most:
- Past growth may not repeat.
- Share prices can move sharply in either direction.
- Valuation: L&T trades at a PE of 25.49 against an industry PE of 22.89, so earnings need to keep growing to support the price.
- Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.
How to Choose Between Stocks With Rs 10,000-20,000 Crore Profit
Picking from stocks with Rs 10,000-20,000 crore profit comes down to four checks, applied in order.
- Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
- Compare each PE with the industry PE (12.27 to 36.42) and ask whether the growth rate justifies any gap.
- Track net profit growth, the operating margin and the return on equity in every quarterly result.
- Stagger entries across quarters and review institutional holding every reporting season.
Download the Univest iOS App or Univest Android App to track L&T, Sun Pharma, Bajaj Auto and Hindustan Zinc live prices.
Conclusion
Among stocks with Rs 10,000-20,000 crore profit, L&T stands out for the largest market cap at Rs 5,00,275 crore, Sun Pharma for the fastest profit growth, 35.75% a year since FY22, Bajaj Auto for the biggest five-year price gain at 165.89% and Hindustan Zinc for the highest return on equity at 61.13%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing stocks with Rs 10,000-20,000 crore profit should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Stocks With Rs 10,000-20,000 Crore Profit to Watch
Which are the best stocks with Rs 10,000-20,000 crore profit to watch for multibagger potential?
Ans. L&T, Sun Pharma, Bajaj Auto and Hindustan Zinc are the 4 names this list highlights, with market caps of Rs 5,00,275 crore, Rs 4,22,427 crore, Rs 2,81,374 crore and Rs 2,23,984 crore respectively. L&T is notable for the largest market cap at Rs 5,00,275 crore. Sun Pharma stands out for the fastest profit growth, 35.75% a year since FY22. Bajaj Auto offers the biggest five-year price gain at 165.89%. Hindustan Zinc brings the highest return on equity at 61.13%. These are watchlist names for stocks with Rs 10,000-20,000 crore profit, not recommendations, so match each one to your own risk profile and time horizon.
Is Hindustan Zinc a good stock for long-term investors?
Ans. Hindustan Zinc has a return on equity of 61.13%, a PE of 13.12 against an industry PE of 12.27 and a market cap of Rs 2,23,984 crore. Net profit has compounded at 9.48% a year since FY22, and FY26 revenue rose 19.59% while June 2026 quarter net profit grew 144.81%. Long-term returns in stocks with Rs 10,000-20,000 crore profit depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.
Can Sun Pharma become a multibagger from here?
Ans. Sun Pharma has already gained 110.81% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in stocks with Rs 10,000-20,000 crore profit requires earnings to keep growing faster than the market for several years. Net profit has compounded at 35.75% a year since FY22, and FY26 revenue rose 12.69%. At a PE of 34.86 against an industry PE of 36.42, valuation should be checked against that growth before investing.
What is the market cap of L&T, Sun Pharma, Bajaj Auto and Hindustan Zinc?
Ans. As of 20 October 2026, L&T has a market cap of Rs 5,00,275 crore, Sun Pharma has a market cap of Rs 4,22,427 crore, Bajaj Auto has a market cap of Rs 2,81,374 crore and Hindustan Zinc has a market cap of Rs 2,23,984 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on stocks with Rs 10,000-20,000 crore profit.
What are the risks of investing in stocks with Rs 10,000-20,000 crore profit?
Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. L&T trades at a PE of 25.49 against an industry PE of 22.89, so earnings growth needs to hold up.
Is Hindustan Zinc trading below its industry PE?
Ans. Hindustan Zinc trades at a PE of 13.12 against an industry PE of 12.27. A lower PE means investors pay less for each rupee of earnings, but it should be read with growth (net profit has compounded at 9.48% a year since FY22 and FY26 revenue rose 19.59%) and balance sheet strength before drawing a conclusion.
How much do institutions hold in L&T, Sun Pharma, Bajaj Auto and Hindustan Zinc?
Ans. As of the latest reported quarter, FII and DII together hold 62.15% of L&T (19.13% and 43.02%), 36.63% of Sun Pharma (14.36% and 22.27%), 22.55% of Bajaj Auto (9.01% and 13.54%) and 7.21% of Hindustan Zinc (2.36% and 4.85%). Rising institutional holding is a useful signal in stocks with Rs 10,000-20,000 crore profit, though it should be read with earnings trends rather than on its own.
